The model of screening for preeclampsia in the second and third trimesters of gestation
Full Text (PDF)
Liudmyla Berlinska 1 * , Valerie Marichereda 1 , Oleksandr Rohachevskyi 2 , Alla Volyanska 1 , Ganna Lavrynenko 1
More Detail
1 Department of Obstetrics and Gynecology, Odesa National Medical University, Odesa, UKRAINE2 Department of Simulation Medical Technologies, Odessa National Medical University, Odesa, UKRAINE* Corresponding Author

Abstract

Purpose: Preeclampsia (PE) is a specific syndrome of multiple organ insufficiency in case of pregnancy, which is included in the panel of major obstetric syndromes and is among the main causes of maternal morbidity and mortality in the whole world.
Material and methods: We conducted a prospective cohort study of 91 pregnant women to evaluate the effectiveness of integrated use of maternal risk factors (2019 International Federation of Gynecology and Obstetrics recommendations), placenta location (ultrasound at 18-20 weeks of gestation), and serum cystatin C (at 18-36 weeks of gestation) in screening for pe in the second and third trimesters of gestation.
Results: In the subgroup of pregnant women with cystatin C levels greater than 1.0 mg/L (27 women), PE developed in 26 women, which is 96.29% in percentage terms. When calculating GFR for cystatin C in a group with PE there was a significant violation of the renal filtration system -52.46±2.08 (95% CI, 48.39-56.54), while in healthy group the indicator is within normal limits -97.6±1.64 (95% CI, 94.38-100.82). In the analysis of the ratio of cystatin C levels more than 1.0 mg / l and the development of PE, a sensitivity of 98.46%, specificity of 100% and accuracy of 98.9%, p<0.001.
Conclusions: The data show that the combined model of maternal factors, ultrasound of the placenta and serum cystatin C, is prognostically effective in pregnant women in the second and third trimesters of gestation and is a reliable marker for the development of pe.

Keywords

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Original Article

ELECTRON J GEN MED, Volume 20, Issue 3, June 2023, Article No: em473

https://doi.org/10.29333/ejgm/12992

Publication date: 01 May 2023

Online publication date: 25 Feb 2023

Article Views: 1057

Article Downloads: 855

Open Access References How to cite this article